Academic
Publications
FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival

FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival,10.1046/j.1525-1438.2002.01149.x,International Journa

FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival   (Citations: 21)
BibTex | RIS | RefWorks Download
Memarzadeh S, Holschneider CH, Bristow RE, Jones NL, Fu YS, Berek JS, Farias-Eisner R. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival. Int J Gynecol Cancer 2002;12:454-458. The objective of this study was to assess the impact of surgical cytore- duction on the survival of patients with uterine papillary serous carci- noma (UPSC). Patients added to the institutional tumor registries be- tween January 1980 and September 2001 with the diagnosis of UPSC were reviewed. The records of 43 patients who underwent surgical cy- toreduction for FIGO stage III and IV disease were reviewed. The me- dian survival of UPSC patients with microscopic residual disease was significantly improved compared to those with macroscopic residual dis- ease following primary surgical cytoreduction. We conclude that pri- mary surgical cytoreduction resulting in microscopic residual disease is associated with an improvement in recurrence-free survival and overall survival in women with UPSC.
Journal: International Journal of Gynecological Cancer - INT J GYNECOL CANCER , vol. 12, no. 5, pp. 454-458, 2002
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: